SBI Securities’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37K Buy
2,284
+461
+25% +$442 ﹤0.01% 2690
2026
Q1
$2.42K Sell
1,823
-45
-2% -$57 ﹤0.01% 2353
2025
Q4
$2.07K Sell
1,868
-5,286
-74% -$9.48K ﹤0.01% 2363
2025
Q3
$14.8K Sell
7,154
-1,682
-19% -$4.71K ﹤0.01% 1578
2025
Q2
$17.3K Sell
8,836
-3,285
-27% -$5.98K ﹤0.01% 1472
2025
Q1
$21K Buy
12,121
+11,793
+3,595% +$22.3K ﹤0.01% 1310
2024
Q4
$682 Buy
+328
New +$783 ﹤0.01% 2773

Other funds holding CELU

SBI Securities's CELU Position: Q2 2026 in Review

SBI Securities increased its Celularity (CELU) stake by 25% in Q2 2026, buying an estimated $442 and bringing the position to 2,284 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #2690.

SBI Securities first reported a position in CELU in Q4 2024 and has held it in 7 quarters since. The position peaked at $21K in Q1 2025. 8 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • SBI Securities held 2,284 shares of Celularity worth $1.37K as of Q2 2026.
  • SBI Securities bought 461 Celularity shares in Q2 2026, an estimated $442.
  • Celularity made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2690 holding.
  • SBI Securities first reported a position in Celularity in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Celularity position peaked at $21K in Q1 2025.
  • 8 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.